ReviewBiochemistry2026
Metal Binding to Tau Protein: Physiological and Pathological Relevance.
Review in Biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The microtubule-associated protein tau is an intrinsically disordered protein that exhibits a remarkable diversity of functions, while its amyloid aggregation is the hallmark of tauopathies, including Alzheimer's disease. This perspective article discusses recent advances in understanding copper and zinc binding to tau, the nature of the metal binding sites, and its physiological and pathological relevance. First, an argument for a potential role of metal binding in the interactome and diverse functionality of tau is provided, since metal coordination occurs in regions of tau engaged in its interaction with key binding partners. Then, the role of metal binding to tau in modulating its structural dynamics and amyloid aggregation behavior is discussed, with an emphasis on a potential role of metal ions in the morphological diversity of tau fibrils. Finally, the interplay between metal binding and post-translational modifications (PTMs) of tau is examined in physiological and pathological contexts, discussing how PTMs may influence metal coordination and how metals may modulate PTM processing of tau. Overall, this perspective delineates the exciting future of bioinorganic research related to tau protein, underscoring the importance of investigating the role of metal ions in tau biology as functional modulators and/or drivers of pathological transitions, linking metal homeostasis to tau physiology and disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.